STOCK TITAN
  1. Home
  2. Sec-filings
  3. GCTK
  4. [EFFECT] Glucotrack, Inc. SEC Filing

[EFFECT] Glucotrack, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 27, 2026 4:05 P.M.
Form: S-3
CIK: 0001506983
Company Name: Glucotrack, Inc.
File Number: 333-292695

Source: View Original Filing on SEC EDGAR

Stock GCTK logo
Glucotrack

NASDAQ:GCTK

GCTK Rankings

#6807 Ranked by Market Cap
N/A Ranked by Dividends
#109 Top Loser

GCTK Latest News

Jan 29, 2026
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
Dec 30, 2025
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
Nov 13, 2025
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
Nov 3, 2025
Glucotrack, Inc. Encourages Shareholders to Vote
Oct 29, 2025
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

GCTK Latest SEC Filings

Jan 29, 2026
[PRE 14A] Glucotrack, Inc. Preliminary Proxy Statement
Jan 29, 2026
[8-K] Glucotrack, Inc. Reports Material Event
Jan 27, 2026
[424B3] Glucotrack, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 13, 2026
[S-3] Glucotrack, Inc. Shelf Registration Statement
Nov 13, 2025
[8-K] Glucotrack, Inc. Reports Material Event

GCTK Stock Data

3.11M
858.95k
5.55%
0.81%
4.51%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
RUTHERFORD